1. Introduction
===============

Elderly are considered one of the most vulnerable groups in societies all over the world, and special attention is typically paid to them. In recent years, due to lower mortality rates and improved health and increased life expectancy, the number of elders is more than in any period in history. For every 10 people in the world, a person is over 65 years old. In Iran, also by increasing the proportion, the number of elders has increased, and, according to the latest statistics, 7.8% of the country's population is made up of elder people; due to population growth, it is predicated that the levels during the next decade will reach to 16% of the total population ([@b1-epj-08-3193]). The prevalence of physical disabilities will increase with increasing the population ageing; thus this inability results from many causes, among them the loss of mobility is of greatest importance ([@b2-epj-08-3193]). Osteoarthritis is of the most common joint disease and disability in most countries of the world ([@b1-epj-08-3193], [@b2-epj-08-3193]). It has a higher incidence rate before age 50 in men and later in women ([@b2-epj-08-3193]). The knee is one of the most common joints, where almost 10% of the population has had knee pain over 65 years ([@b3-epj-08-3193]), and about 25% of people aged 55 years and older have reported a history of knee pain in the past few years. Treatment for osteoarthritis includes medications, surgery, and complementary therapies. However, these therapies are not completely effective. Some studies have shown that the use of nonsteroidal anti-inflammatory drugs (NSAIDS) may increase heart disease and cardiovascular or gastrointestinal disorders ([@b4-epj-08-3193], [@b5-epj-08-3193]). In a study, it was suggested that nonsteroidal anti-inflammatory drug commonly are prescribed, which will increase the degradation of joint cartilage in osteoarthritis through the inhibition of the synthesis of cartilage matrix ([@b6-epj-08-3193]). Thus many researchers are looking for drugs, while effective, that have fewer adverse side effects, among which herbal drugs may be mentioned. From the earliest times, the therapeutic effects of medicinal plants have been considered. It is a common belief in Islamic countries that Nigella sativa is a general healer to cure diseases but cannot prevent aging and death. The plant, with the scientific name of Nigella sativa, is a member of the Ranunculaceae family: it has white flowers, white or blue with milky grains that become black in contact with air. Nigella sativa has a medical and religious history. It is native to southern Europe and North Africa and Asia and had been used to treat illnesses by ancient Egyptian and Greek doctors and Avicenna ([@b7-epj-08-3193]). Nigella sativa oil is composed of 30% by weight of p-cymene, which is the most original composition, and 61.48% of the weight is composed of the volatile oil. Nigella sativa seeds contain fat, vitamins, minerals, proteins, essential amino acids, and carbohydrates ([@b8-epj-08-3193]). Nigella sativa seed is a rich source of essential fatty and unsaturated acids. The main unsaturated fatty acids are linoleic acid and oleic acid. There are also other compounds in seeds, such as phospholipids, carotene, calcium, iron, and potassium ([@b9-epj-08-3193]). Various evidence suggests that, due to the beneficial use of this plant on kidney function, blood pressure regulation system, the ability to detoxify the liver, the respiratory system's ability to dispose of waste, the production of sweat, and textured milk, available evidence indicates that components of Nigella sativa oil and active components, especially TQ, have antioxidant and anti-inflammatory, anti-inflammatory, and analgesic properties that are applied through the suppression of inflammatory mediators such as prostaglandins and thymoquinone ([@b10-epj-08-3193]). Hajhashemi and colleagues noted that Nigella sativa oil has 20 different chemical compositions, among those the semen parameters and thymoquinone are two major components, which are both systemic and topical prescriptions of anti-inflammatory and analgesic properties ([@b11-epj-08-3193]). A study that Roghani and colleagues conducted on rats found that oral prescription of Nigella sativa for two months resulted in a significant reduction in pain in the rats ([@b12-epj-08-3193]). According to a mobility disability caused by osteoarthritis among the elderly, a lot of side effects of synthetic drugs and multiple medications by the elderly exist with no certain cure for it; thus the prevalence of musculoskeletal disorders has been reported in older people in Sabzevar City, especially in the knee joint ([@b13-epj-08-3193], [@b14-epj-08-3193]). This study was to evaluate the topical impact of Nigella sativa oil and oral acetaminophen on knee osteoarthritis in the elderly residing in a parents' nursing home in Sabzevar City of Iran.

2. Material and Methods
=======================

2.1. Study setting and participants
-----------------------------------

This study was conducted as a clinical trial (crossover) from November 21, 2014, to January 20, 2014. Procedure of the study was justified in elderly patients with osteoarthritis of the knee in elderly residing in a parents' nursing home in Sabzevar City in Iran.

2.2. Inclusion criteria
-----------------------

All patients were evaluated before inclusion in this study. Age over 65 years diagnosis of knee osteoarthritis, according to American College Rheumatology diagnostic criteria, included 1) knee pain on most days of the last month; 2) crepitus (joint sound in active motion); 3) morning stiffness less than 30 minutes; and 4) inflation in the examination of the knee bone, respectively ([@b15-epj-08-3193]). Knee osteoarthritis was confirmed by a physician, and the use of radiography, knee pain in the past 24 hours, so that the average linear measure-visual pain (VAS: visual analogue score) is between 4--7 cm, and the lack of inflammatory diseases, metabolic disorders (diabetes), cancer or malignant diseases, symptoms or a history of liver or kidney failure, treatment with oral corticosteroids in the past 4 weeks or injection in the last 6 months, no fever, lack of sensitivity and allergy Nigella sativa oil, not wanting to continue to participate in the study, supplementation with vitamins and minerals or other nutritional supplements, painkillers were the exit standards of the study.

2.3. Intervention
-----------------

After obtaining written consent for their demographic questionnaire, seniors eligible for the study were randomly divided into two groups. In the first stage, for the first group about 1 ml Nigella sativa oil was applied on the knee joint three times a day every 8 hours for 1 week. The massaging method was done with the entire palm in a way that continued for 5 minutes, massaged in a clockwise direction at the front and sides of the knee joint. It should be noted that the Nigella sativa oil used was owned by Barij-e-Kashan; for all subjects, it was maintained away from sunlight and at ambient temperature. The second group was given 325 mg acetaminophen tablets 3 times a day every 8 hours for 3 weeks. Then a 1-month period without medication to wash out was given to each group, and then each treatment group received the contrary drug in the same way as above. If patients were taking the drug irregularly or because of pain medication or because other treatment methods were used, or for whatever reason, and were not able to continue the treatment and completion of the study, they were excluded from the study.

2.4. Outcomes
-------------

The pain intensity was determined using the visual analogue linear scale (VAS) before and after the first and second stages of the study. The standard was a 10-inch ruler on which the patient were asked to rate his or her pain intensity from 0 to 10. Before taking the medication, individuals marked their pain on the ruler. Mild pain distances of 0 to 3, 4 to 7 moderate pain, and severe pain showed 8--10 ([@b16-epj-08-3193]). Response to treatment was measured for reduction of more than 5.1 cm on the VAS scale in the pain.

2.5. Sample size and statistical analysis
-----------------------------------------

In the sample size required by the consultant statistics with 95% confidence level and 5% error and 90% power, 37 patients were assessed as probable loss by 10% to 42%. Data analysis was performed with an R software mixed model.

2.6. Research ethics
--------------------

The study protocol was approved by the Ethics Committee of the National Research Center, Cairo, Egypt. All patients were informed thoroughly about the study, and each patient was asked to sign a consent form. Only motivated and cooperative patients, who accepted the periodic recall visits and agreed to sign the consent form, were enrolled.

3. Results
==========

Forty-two patients participated in this study (two patients were excluded due to noncooperation). Eighteen (45%) were male and 22 (55%) were female, with a mean age of 75.66 ± 8.9 years and average weight of 69.67 ± 14.33 kg. Their activity was less than 1 hour a day for being exposed to sunlight 1 to 2 hours per day. R software mixed model showed that mean of pain intensity was 4.23 ± 0.31 and 4.76 ± 0.31 in the Nigella sativa oil and oral acetaminophen groups, respectively. Also, topical use of Nigella sativa oil and oral acetaminophen reduced knee pain in elder patients (p=0.0001). The R software mixed model showed that pain intensity relief was 0.53 higher in Nigella sativa oil compared with oral acetaminophen (p=0.01).

4. Discussion
=============

Nigella sativa (N. Sativa) has a distinct reputation in Eastern medicine, and it is a commonly used ingredient in many recipes in South Asia and elsewhere ([@b17-epj-08-3193]). In this study, the topical use of 1 cc Nigella sativa oil 3 times a day for 3 weeks reduced knee pain compared with oral acetaminophen in elderly patients with knee osteoarthritis with moderate pain. More researches have recognized analgesic, antispasm, and anti-inflammatory effects in in vivo and in vitro studies ([@b18-epj-08-3193], [@b19-epj-08-3193]). Our results were consistent with the results of Gheita's study, which was performed on 40 women, who received Nigella sativa oil capsules 500 mg twice daily compared with a placebo, he and his colleagues reported that pain was reduced significantly due to improvement of patients ([@b20-epj-08-3193]). Also Tekeoqlu and colleagues conducted a study on mice by measuring TNF-α IL-1β, which showed that TQ (Nigella sativa) demonstrated that the substance can significantly suppress arthritis in mice ([@b21-epj-08-3193]). Bashir and colleagues (2010) showed that the ethanol extract of nigella sativa has a significant analgesic effect in albino rats, but the effect on the reduction of sodium diclofenac was less than that, which was not consistent with our research results because, in our study, the effect of Nigella sativa oil was more significant than acetaminophen for pain relief ([@b22-epj-08-3193]). Yet, no study has examined the topical use of Nigella sativa oil on pain; however, Emami Razavi and colleagues conducted a study on 154 patients with knee pain. They treated patients in three groups as involved groups with frankincense oil-sesame oil in the control group, and diclofenac gel for the positive control group for six weeks. Their study confirmed the potential effects of topical administration of frankincense oil in the symptomatic treatment of knee pain ([@b23-epj-08-3193]). Thymoquinone is one of four active ingredients in aqueous extracts of Nigella cumin. Thymoquinone is reported to inhibit oxidative stress. One way of decreasing oxidative stress is to induce glutathione. Mohamed et al. tested the impact of thymoquinone (1 mg/kg, injected in the tail vein) in rats. They reported that thymoquinone may have a role in treatment of multiple sclerosis ([@b24-epj-08-3193]). The anti-inflammatory effect of the N. Sativa was observed, and studies have shown that black cumin reduced the pain. Ghannadi et al. suggest that Nigella sativa has analgesic and anti-inflammatory effects due to its polyphenols ([@b25-epj-08-3193]). Naggar and colleagues also stated that Nigella sativa extract has analgesic effect on the CNS ([@b24-epj-08-3193]). Several studies also showed that Nigella sativa inhibits inflammation with reducing the nitric oxide production and inhibiting cytokines interleukin-1 and 6 and the transcription factor βK inflammation. Also, some studies have stated that Nigella sativa reduced the synthesis of MCP-1, TNF-α, and IL-β1 and inhibited the histone deacetylases Cox-2 as well as demonstrated its anti-inflammatory properties with the induction of histone hyper acetylation. Nigella sativa oil has demonstrated a mild effect on the expression of Cox-1 and PGE-2 in animal models of respiratory allergies ([@b26-epj-08-3193]--[@b28-epj-08-3193]).

5. Conclusions
==============

This study showed that topical use of Nigella sativa oil can be more effective in reducing knee pain in elderly patients than acetaminophen, which is typically used as a safe supplement for the elderly. Further investigation is needed to establish the mechanisms involved. It is also recommended that the consumption of Nigella sativa oil be continued for a longer period of time.
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